316
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India

, , ORCID Icon, , & ORCID Icon
Pages 625-640 | Published online: 27 Nov 2021